ArticleOPEN ACCESS

Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the de Novo Pathway between 2011 and 2019

JAMA Internal Medicine
DOI: 10.1001/jamainternmed.2020.3214
23Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Johnston, J. L., Dhruva, S. S., Ross, J. S., & Rathi, V. K. (2020, December 1). Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the de Novo Pathway between 2011 and 2019. JAMA Internal Medicine. American Medical Association. https://doi.org/10.1001/jamainternmed.2020.3214

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free